Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myositis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06698796
What this trial is testing

Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

Who this might be right for
DermatomyositisPolymyositis
Pfizer 211
Early research (Phase 1)UnknownNCT06316076
What this trial is testing

Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisIdiopathic Inflammatory Myopathies+1 more
RenJi Hospital 48
Early research (Phase 1)Not Yet RecruitingNCT07544225
What this trial is testing

Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases

Who this might be right for
Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)Sjogren's Disease With Dry Eyes+2 more
Gustave Roussy, Cancer Campus, Grand Paris 6
Early research (Phase 1)Looking for participantsNCT07184450
What this trial is testing

Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases

Who this might be right for
Juvenile Dermatomyositis (JDM)Polyarticular Juvenile Idiopathic ArthritisSystemic Sclerosis (SSc)+1 more
Chongqing Precision Biotech Co., Ltd 11
Testing effectiveness (Phase 2)Study completedNCT03529955
What this trial is testing

Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant Dermatomyositis

Who this might be right for
Dermatomyositis, Adult Type
Tulane University 8
Large-scale testing (Phase 3)Study completedNCT01862926
What this trial is testing

Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD

Who this might be right for
Interstitial Lung DiseaseSclerodermaIdiopathic Inflammatory Myositis+1 more
Royal Brompton & Harefield NHS Foundation Trust 104
Not applicableStudy completedNCT05890833
What this trial is testing

The Risk of Falls Index for Patients With Neuromuscular Disorders

Who this might be right for
Inclusion Body MyositisMyotonic DystrophyFacioscapulohumeral Muscular Dystrophies+3 more
LMU Klinikum 30
Post-approval studies (Phase 4)UnknownNCT01151644
What this trial is testing

Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisSystemic Lupus Erythematosus (SLE)+9 more
University of Sao Paulo 5,000
Post-approval studies (Phase 4)Enrolling By InvitationNCT06438679
What this trial is testing

3T Therapy in the Treatment of MDA5-positive Dermatomyositis

Who this might be right for
Dermatomyositis
Second Affiliated Hospital, Zhejiang University, School of Medicine 133
Not applicableStudy completedNCT00001973
What this trial is testing

Studies on Abnormal Bone From Patients With Polyostotic Fibrous Dysplasia and McCune Albright Syndrome

Who this might be right for
Polyostotic Fibrous Dysplasia
National Institute of Dental and Craniofacial Research (NIDCR)
Not applicableUnknownNCT03743675
What this trial is testing

Influence of Aerobic Training and Weight Loss on Skeletal Muscle Inflammatory Markers and Muscle Protein Balance in Older Adults

Who this might be right for
Overweight and ObesityInflammation; MuscleSedentary Lifestyle
Miami University 60
Not applicableStudy completedNCT00001167
What this trial is testing

Ultrasound Evaluation of Tongue Movements in Speech and Swallowing

Who this might be right for
Otorhinolaryngologic DiseaseOtorhinolaryngologic NeoplasmPharyngeal Neoplasm+2 more
National Institutes of Health Clinical Center (CC) 570
Not applicableEnrolling By InvitationNCT05859997
What this trial is testing

Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Sjogren's SyndromeSystemic Sclerosis+3 more
Bioray Laboratories 15
Not applicableStudy completedNCT03492242
What this trial is testing

Immune CHeckpoint Inhibitors Monitoring of Adverse Drug ReAction

Who this might be right for
ArthritisCancerCardiac Disease+5 more
Groupe Hospitalier Pitie-Salpetriere 1,000
Not applicableStudy completedNCT06002750
What this trial is testing

Evaluation of Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis of Their Relationship With Inflammation

Who this might be right for
DermatomyositisMyocardial RepolarizationInflammation
The Third People's Hospital of Hangzhou 100
Not applicableStudy completedNCT04486261
What this trial is testing

High-intensity Strength Training in Myositis

Who this might be right for
MyositisDermatomyositisPolymyositis+1 more
Rigshospitalet, Denmark 34
Testing effectiveness (Phase 2)WithdrawnNCT02980198
What this trial is testing

Study of IFN-K in Dermatomyositis

Who this might be right for
Dermatomyositis
Neovacs
Testing effectiveness (Phase 2)Ended earlyNCT05000216
What this trial is testing

COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

Who this might be right for
Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)Pemphigus Vulgaris+6 more
National Institute of Allergy and Infectious Diseases (NIAID) 258
Large-scale testing (Phase 3)Study completedNCT05437263
What this trial is testing

Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis

Who this might be right for
Dermatomyositis
Priovant Therapeutics, Inc. 241
Early research (Phase 1)Looking for participantsNCT06686524
What this trial is testing

Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM)

Who this might be right for
Dermatomyositis, JuvenileDermatomyositis
Chongqing Precision Biotech Co., Ltd 18
Next Page